ULTRAGENYX PHARMACEUTICAL INC. Finance Lease, Principal Payments
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Finance Lease, Principal Payments of $149.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2020-10-27
- ULTRAGENYX PHARMACEUTICAL INC. finance lease, principal payments for the quarter ending 2020-09-30 was $58.00K.
- ULTRAGENYX PHARMACEUTICAL INC. finance lease, principal payments for the quarter ending 2020-06-30 was $58.00K.
- ULTRAGENYX PHARMACEUTICAL INC. finance lease, principal payments for the quarter ending 2020-03-31 was $33.00K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month |
|---|---|---|---|
| 2020-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $116.00K derived: sum of 2 quarters · filed 2020-10-27 | $149.00K 10-Q · filed 2020-10-27 |
| 2020-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $91.00K 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $33.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |